Defective tolerance to the toxic and metabolic effects of interleukin 1

Endocrinology

Volumn 128, Issue 3, 1991, Pages 1668-1672

  Mengozzi, Manuela ^a   Ghezzi, Pietro ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GLUCOSE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; BODY WEIGHT; CORTICOSTERONE; DRUG TOLERANCE; EATING; HYPOGLYCEMIA; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0025760665     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo-128-3-1668     Document Type: Article

References (28)

1. Beutler B, Cerami A 1987 Cachectin: More than a tumor necrosis factor. N Engl J Med 316:379-385
2. Dinarello CA 1984 Interleukin-1. Rev Infect Dis 6:51-94
3. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry SF 1988 Cach-ectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167:1211-1227
4. Socher SH, Friedman A, Martinez D 1988 Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J Exp Med 167:1957-1962
5. Fraker DL, Stovroff MC, Merino MJ, Norton JA 1988 Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 1968:95-105
6. Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA 1989 Interleukin-l-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest 84:228-235
7. del Rey A, Besedovsky H 1987 Interleukin 1 affects glucose homeostasis. Am J Physiol 253.-R794-R798
8. Besedovsky H, del Rey A, Sorkin E, Dinarello CA 1986 Immuno-regulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652-654
9. Butler LD, Layman NK, Riedl PE, Cain RL, Shellhaas J, Evans GF, Zuckerman SH 1989 Neuroendocrine regulation of in vivo cytokine production and effects. I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-a. J Neuroimmunol 24:143-153
10. Snyder DS, Unanue ER 1982 Corticosteroids inhibit murine macrophage la expression and interleukin 1 production. J Immunol 129:1803-1805
11. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A 1986 Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232:977-980
12. Beeson PB 1947 Tolerance to bacterial pyrogens. I. Factors influencing its development. J Exp Med 86:29-34
13. Grunfeld C, Wilking H, Neese R, Gavin LA, Moser AH, Gulli R, Serio MK, Feingold KR 1989 Persistence of the hypertriglyceri-demic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res 49:2554-2560
14. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA 1988 Interleukin 1 induces a shock-like state in rabbits. J Clin Invest 81:1162-1172
15. Bertini R, Bianchi M, Ghezzi P 1988 Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med 1967:1708-1712
16. Wallach D, Holtmann H, Engelmann H, Nophar Y 1988 Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. J Immunol 140:2994-2999
17. Vogel SN, Kaufman EN, Tate MD, Neta R 1988 Recombinant interleukin-la and recombinant tumor necrosis factor a synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun 56:2650-2647
18. Philip R, Epstein LB 1986 Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature 323:86-89
19. Waage A, Espevik T 1988 Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J Exp Med 1967:1987-1992
20. Fraker DL, Langstein HN, Norton JA 1989 Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity. J Exp Med 1970:1015-1020
21. File SE 1982 The rat corticosterone response: Habituation and modification by chlodiazepoxide. Physiol Behav 29:91-95
22. McCarthy DD, Kluger MJ, Vander AJ 1986 Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted rats. Physiol Behav 36:745-749
23. Mrosovsky N, Molony LA, Conn CA, Kluger MJ 1989 Anorexic effects of interleukin 1 in the rat. Am J Physiol 257: R1315-R1321
24. Otterness IG, Golden HW, Brissete WH, Seymour PA, Daumy GO 1989 Effects of continuously administered murine interleukin-la tolerance development and granuloma formation. Infect Immun 57:2742-2750
25. Dinarello CA, Cannon JG, Mier JW, Bernheim HA, LoPreste G, Lynn DL, Love RN, Webb AC, Auron PE, Reuben RC, Rich A, Wolff SM, Putney SD 1986 Multiple biological activities of human recombinant interleukin 1. J Clin Invest 77:1734-1739
26. 125I-labeled IL lβ in a human large granular lymphocyte cell line. J Immunol 137:3183-3188
27. Akahoshi T, Oppenheim JJ, Matsushima K 1988 Interleukin 1 stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin (s). J Clin Invest 82:1219-1224
28. Bertini R, Bianchi M, Mengozzi M, Ghezzi P 1989 Protective effect of chlorpromazine against the lethality of interleukin-1 in adre-nalectomized or actinomicin D-sensitized mice. Biochem Biophys Res Commun 165:942-946